JP2007309851A - エキノコックス多包虫症の診断法 - Google Patents
エキノコックス多包虫症の診断法 Download PDFInfo
- Publication number
- JP2007309851A JP2007309851A JP2006140783A JP2006140783A JP2007309851A JP 2007309851 A JP2007309851 A JP 2007309851A JP 2006140783 A JP2006140783 A JP 2006140783A JP 2006140783 A JP2006140783 A JP 2006140783A JP 2007309851 A JP2007309851 A JP 2007309851A
- Authority
- JP
- Japan
- Prior art keywords
- echinococcus
- antigen
- antibody
- em18r2
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000244160 Echinococcus Species 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 33
- 206010014096 Echinococciasis Diseases 0.000 title abstract description 8
- 208000009366 Echinococcosis Diseases 0.000 title abstract description 8
- 201000003808 Cystic echinococcosis Diseases 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 claims abstract description 35
- 102000036639 antigens Human genes 0.000 claims abstract description 35
- 108091007433 antigens Proteins 0.000 claims abstract description 35
- 210000002966 serum Anatomy 0.000 claims abstract description 16
- 239000000523 sample Substances 0.000 claims abstract description 13
- 210000004899 c-terminal region Anatomy 0.000 claims abstract description 8
- 238000002405 diagnostic procedure Methods 0.000 claims description 8
- 238000007689 inspection Methods 0.000 abstract description 4
- 238000007796 conventional method Methods 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000012528 membrane Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 239000002245 particle Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 102000010111 Ezrin/radixin/moesin Human genes 0.000 description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 108050001788 Ezrin/radixin/moesin Proteins 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 238000003317 immunochromatography Methods 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 241000282421 Canidae Species 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000003593 chromogenic compound Substances 0.000 description 4
- 238000003119 immunoblot Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 3
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000012752 Hepatectomy Methods 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000854648 Homo sapiens Ezrin Proteins 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241001193944 Polycystis Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 102000021178 chitin binding proteins Human genes 0.000 description 1
- 108091011157 chitin binding proteins Proteins 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- YKYHYFKZYBXMCZ-UHFFFAOYSA-N ethyl 1,3-benzothiazole-2-sulfonate Chemical compound C1=CC=C2SC(S(=O)(=O)OCC)=NC2=C1 YKYHYFKZYBXMCZ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 108010071525 moesin Proteins 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000010882 preoperative diagnosis Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 244000054366 zoonotic parasite Species 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006140783A JP2007309851A (ja) | 2006-05-19 | 2006-05-19 | エキノコックス多包虫症の診断法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006140783A JP2007309851A (ja) | 2006-05-19 | 2006-05-19 | エキノコックス多包虫症の診断法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007309851A true JP2007309851A (ja) | 2007-11-29 |
| JP2007309851A5 JP2007309851A5 (enrdf_load_stackoverflow) | 2009-07-30 |
Family
ID=38842831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006140783A Pending JP2007309851A (ja) | 2006-05-19 | 2006-05-19 | エキノコックス多包虫症の診断法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007309851A (enrdf_load_stackoverflow) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101949926A (zh) * | 2010-08-04 | 2011-01-19 | 浙江大学 | 人体包虫病胶体金免疫层析试尿液快速诊断试纸卡 |
| CN102539782A (zh) * | 2011-10-09 | 2012-07-04 | 中国疾病预防控制中心寄生虫病预防控制所 | 检测囊型包虫病和泡型包虫病的免疫层析试条及制备方法 |
| CN106092988A (zh) * | 2016-06-08 | 2016-11-09 | 新疆医科大学第附属医院 | 基于soi自发光特性的包虫蛋白分子的快速检测方法 |
| CN111381021A (zh) * | 2020-03-04 | 2020-07-07 | 南京亿科人群健康研究院有限公司 | 一种基于检测包虫特异性抗原及其编码基因的早期诊断方法 |
| CN111521816A (zh) * | 2020-04-21 | 2020-08-11 | 沈阳农业大学 | 牛细粒棘球蚴病时间分辨荧光免疫层析检测试纸条及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625298A (ja) * | 1992-07-13 | 1994-02-01 | Meito Sangyo Kk | 多包虫由来の抗原並びにそれを用いた診断用試薬及び診断方法 |
| JP2005029558A (ja) * | 2003-06-16 | 2005-02-03 | Japan Science & Technology Agency | エキノコックス症（多包虫症）検査用抗原 |
-
2006
- 2006-05-19 JP JP2006140783A patent/JP2007309851A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625298A (ja) * | 1992-07-13 | 1994-02-01 | Meito Sangyo Kk | 多包虫由来の抗原並びにそれを用いた診断用試薬及び診断方法 |
| JP2005029558A (ja) * | 2003-06-16 | 2005-02-03 | Japan Science & Technology Agency | エキノコックス症（多包虫症）検査用抗原 |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101949926A (zh) * | 2010-08-04 | 2011-01-19 | 浙江大学 | 人体包虫病胶体金免疫层析试尿液快速诊断试纸卡 |
| CN102539782A (zh) * | 2011-10-09 | 2012-07-04 | 中国疾病预防控制中心寄生虫病预防控制所 | 检测囊型包虫病和泡型包虫病的免疫层析试条及制备方法 |
| CN106092988A (zh) * | 2016-06-08 | 2016-11-09 | 新疆医科大学第附属医院 | 基于soi自发光特性的包虫蛋白分子的快速检测方法 |
| CN106092988B (zh) * | 2016-06-08 | 2019-03-01 | 新疆医科大学第一附属医院 | 基于soi自发光特性的包虫蛋白分子的快速检测方法 |
| CN111381021A (zh) * | 2020-03-04 | 2020-07-07 | 南京亿科人群健康研究院有限公司 | 一种基于检测包虫特异性抗原及其编码基因的早期诊断方法 |
| CN111521816A (zh) * | 2020-04-21 | 2020-08-11 | 沈阳农业大学 | 牛细粒棘球蚴病时间分辨荧光免疫层析检测试纸条及其制备方法 |
| CN111521816B (zh) * | 2020-04-21 | 2023-03-21 | 沈阳农业大学 | 牛细粒棘球蚴病时间分辨荧光免疫层析检测试纸条及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101892182B1 (ko) | 에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법 | |
| JP6325553B2 (ja) | エールリヒア抗体の検出のためのペプチド、デバイス、および方法 | |
| JP2015504420A (ja) | ライム病抗体の検出のためのペプチドおよび方法 | |
| CN112964884A (zh) | 一种诊断标志物及其在covid-19诊断及冠状病毒既往感染检测中的应用 | |
| US12037365B2 (en) | Peptides and their use in diagnosis | |
| BR112016016737B1 (pt) | Composição, método para detectar numa amostra um anticorpo para um epítopo de um antígeno de anaplasma, método para o diagnóstico da anaplasmose num sujeito, kit, e método para identificar as espécies de anaplasma infectando um sujeito | |
| WO2015151128A1 (en) | Method for rapid detection of infection from caga positive helicobacter pylori and diagnostic kit therefor | |
| KR101805451B1 (ko) | 아나플라즈마 파고사이토필리움 균주의 탐지용 조성물, 및 이를 포함하는 면역진단키트 | |
| Kim et al. | Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay | |
| JP2007309851A (ja) | エキノコックス多包虫症の診断法 | |
| FR3062919A1 (fr) | Methode de dosage immunologique d'anticorps specifiques d'antigenes de virus de la famille des poxviridae | |
| HUE027340T2 (en) | Dual Immunodeficiency Test for Antibody Detection | |
| US9658227B2 (en) | Recombinant GRA antigens and the use of same for early diagnosis of toxoplasmosis | |
| Siqueira | Identification of new antigens for the diagnosis of visceral leishmaniasis: application in immunochromatography | |
| Ozturk et al. | Comparison of the multi-epitope recombinant antigen DIPOL and hydatid fluid for the diagnosis of patients with cystic echinococcosis | |
| CN113671190A (zh) | 一种诊断标志物及其在covid-19诊断及冠状病毒既往感染检测中的应用 | |
| US20230109906A1 (en) | Assay and kit for live antigen detection and monitoring of neurocysticercosis | |
| US11899015B1 (en) | Chimeric recombinant proteins and recombinant protein panels for the diagnosis of Lyme disease in animals and humans | |
| US20240142464A1 (en) | Methods, device, kit and compositions for detecting feline lungworm | |
| JP5582521B2 (ja) | 嚢虫症診断用抗原の精製方法 | |
| KR101779443B1 (ko) | 브루셀라병 진단용 형광면역진단키트 | |
| WO2025028655A1 (ja) | 梅毒トレポネーマ・パリダム（Ｔｒｅｐｏｎｅｍａ ｐａｌｌｉｄｕｍ）抗原４７ｋＤａ（ＴｐＮ４７）を抗原として用いた免疫分析方法 | |
| CN113671183A (zh) | 一种诊断标志物及其在covid-19诊断及冠状病毒既往感染检测中的应用 | |
| CN112180096A (zh) | 用于诊断线虫感染的新测定法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20080421 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080422 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080609 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080610 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090514 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090514 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090514 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090515 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090618 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111128 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120403 |